The economic burden of the ankylosing spondylitis in the Czech Republic: comparison between 2005 and 2008

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F13%3A10159128" target="_blank" >RIV/00216208:11110/13:10159128 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11130/13:10159128 RIV/00216208:11120/13:43907495 RIV/00216208:11160/13:10159128 RIV/62157124:16370/13:43872380 RIV/00023728:_____/14:#0003046
Result on the web
<a href="http://link.springer.com/article/10.1007/s00296-012-2542-x/fulltext.html" target="_blank" >http://link.springer.com/article/10.1007/s00296-012-2542-x/fulltext.html</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s00296-012-2542-x" target="_blank" >10.1007/s00296-012-2542-x</a>

Result language
angličtina
Original language name
The economic burden of the ankylosing spondylitis in the Czech Republic: comparison between 2005 and 2008
Original language description
To investigate the burden of ankylosing spondylitis in the Czech Republic as a baseline for future health economic evaluations. Data were obtained from two cross-sectional studies Beda I (2005) and Beda II (2008), performed in 1,008 and 509 patients, respectively. Methodology used was Cost-of-Illness prevalence-based analysis bottom-up approach. Analysis was performed from payer (health insurance companies) and societal perspective (including productivity costs using friction cost approach). Mean age ofsample in Beda I and Beda II was 50.2 and 52.5 years, male were present by 61.0 and 62.7 %; average disease duration was 23.0 and 26.4 years, respectively. Mean total annual costs per patient in the sample were Euro4,782 in Beda I and Euro5806 in Beda II. Average direct costs per patient in the sample per year are estimated at Euro1,812 (Beda I) and Euro2,588 (Beda II) with the average productivity costs Euro2,970 (Beda I) and Euro3,218 (Beda II). We observed a small decrement in percen
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FR - Pharmacology and apothecary chemistry
OECD FORD branch
—

Project
—
Continuities
S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)